Woops, there's no exact match to what you are looking for. But we selected relevant content that you might also be interested in:
The challenges of a cell & gene therapy supply chain - part 4
Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 4] - Forecasting CGT demand and adapting the supply...
Read more
The challenges of a cell & gene therapy supply chain - part 3
Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 3] - Optimal manufacturing capacity
Read more
The challenges of a cell & gene therapy supply chain - part 2
Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 2] - Probabilistic simulations and digital twin for...
Read more
The hard balance between a short shelf life and low drug waste
A product's shelf life is a central part of every clinical trial. In some situations, shelf lives can become a problem for clinical supply chain managers,...
Read more
The challenges of a cell & gene therapy supply chain
Designing high-performance, risk-controlled, and scalable cell & gene supply chains with a digital twin [PART 1] - The challenges of a cell & gene therapy supply...
Read moreReady to optimize your clinical trial supply chain?
